Also found in: Medical.
NESPNovel Erythropoiesis Stimulating Protein
NESPNeuroendocrine Secretory Protein
NESPNurse Educator Scholarship Program
NESPNavy EHF Satellite Program
NESPNational Environmental Studies Project
NESPNational Education Supercomputer Program
NESPNortheastern Society of Periodontists
NESPNetwork Enabling System Partner
NESPNetwork of Single Professionals (est. 2007)
NESPNational Economic Security Program
NESpNintendo Entertainment System Portable
NESPNew Equipment Support Package
NESPNormalized Effective Signal Power
NESPNew England Street Performance (automobile club)
References in periodicals archive ?
Following ethical approval from the Whitireia Research and Ethics Committee, an information sheet and link to the voluntary, anonymous online survey was distributed to preceptors of new graduates via NESP clinical partners/programme stakeholders.
COL NESP MSPA 0,0-0,10 m Fontes ajifer 38,07 364,33 1116,16 a (FN) ureia 38,79 388,50 1260,33 a SA 39,92 423,16 1072,25 b Doses 0 40,66 359,33 1380,66 a (DN) 100 38,90 434,77 1298,22 a 200 37,20 357,11 864,55 c 400 38,95 416,77 1054,22 b FN 0,80 ns 1,92 ns 4,73 * DN 1,38 ns 2,60 ns 20,25 ** FN x DN 1,52 ns 4,32 ** 1,18 ns CV (%) 9,25 18,82 13,63 0,10-0,20 m Fontes ajifer 34,00 211,41 -- (FN) ureia 35,57 155,75 -- SA 35,75 175,50 -- Doses 0 34,16 255,33 a -- (FN) 100 36,92 146,22 b -- 200 37,64 160,66 b -- 400 31,71 161,33 b -- FN 0,29 ns 3,29 ns -- DN 1,74 ns 7,79 ** -- FN x DN 0,15 ns 0,75 ns -- CV% 17,60 29,78 -- *e **significativo a 5 e 1%, respectivamente; ns = nao-significativo.
However, these benefits were demonstrated secondary to recombinant erythropoietin therapy and similar studies have not been conducted with the NESP product.
The NESP is characterized by a strong positive magnetic anomaly and consists of plutonic rocks mainly and sporadic supracrustal belts ranging in age from Eo- to Neoarchean.
NESP currently operates from two sites in Derwentside but thanks to strong growth the business will be moving to one large base in Stanley this year.
Locatelli F, Olivares J, Walker R, Wilkie M, The European/Australian NESP 980202 Study Group.
Amgen's four late-stage development programs, NESP, IL-1ra, abarelix and SD/01 continued to progress during the first quarter, and the company is planning to launch these products in 2001 and 2002.
In new drug development in Japan, applications in respect of anemia treatment NESP were made for additional indications for anemia for cancer chemotherapy in November 2008 and for additional indications for pre-dialysis renal anemia in December 2008.
A total of 1351 NETP places are available this year, including both semesters, and 175 NESP places.
Prequalification are invited for Provision of consultants to assist the NESP Energy Efficiency component to improve the framework conditions for the introduction of ISO 50001-based Energy Management Systems in the Nigerian industrial sector.
PROD UCT INTRODUCTIONS/APPROVALS II-44 Hamilton Launches AcidLine Syringes II-44 Kyowa Hakko Kirin Introduces NESP Injection 5 g Plastic Syringe in Japan II-44 BD Medical Introduces New BD Sterifill Advance(TM) 50 ML II-44 DMC Medical Introduces NuGen(TM) syringes Range II-44 SCHOTT North America Launches TopPac 20 ml Prefillable Polymer Syringe II-44 DUX Dental Launches ZONEfree syringe II-44 Daiichi Sankyo Introduces PRALIA Subcutaneous Injection 60mg Syringe II-45 BD Introduces BD Glide 6mm Needle II-45 Roselabs Bioscience to Introduce PFL syringes II-45 BD Medical Introduces BD Sterifill Advance II-45 BD Medical Introduces BD Neopak(TM) Prefillable Syringe System II-45 Mallinckrodt Obtains FDA Approval for New Gablofen Prefilled Syringe II-45 West Pharmaceutical Services Introduces B.
The drug, NESP, already has been submitted for approval by the Food and Drug Administration for use in chronic renal failure patients.